title: Amino acid-responsive Crohn's disease: a case study.
abstract: OBJECTIVE
  This paper reviews the clinical course of a case of severe Crohn's disease and discusses the scientific ramifications of a novel treatment approach.
  
  
  METHODS
  A case study of a 37-year-old male with a 22-year history of Crohn's disease whose clinical course had experienced no sustained remissions. The patient was treated with a protocol that utilized serotonin and dopamine amino acid precursors administered under the guidance of organic cation transporter assay interpretation.
  
  
  RESULTS
  Within 5 days of achieving the necessary balance of serotonin and dopamine, the patient experienced remission of symptoms. This remission has been sustained without the use of any Crohn's disease medications.
  
  
  CONCLUSIONS
  In Crohn's disease, it is known that there is an increase of both synthesis and tissue levels of serotonin in specific locations. It is asserted that this is prima facie evidence of a significant imbalance in the serotonin-dopamine system, leading to serotonin toxicity. The hypothesis formulated is that improperly balanced serotonin and dopamine transport, synthesis, and metabolism is a primary defect contributing to the pathogenesis of Crohn's disease.
authors.affiliation: Stein Orthopedic Associates, Plantation, FL, USA;
authors.forename: Alvin
authors.initials: A
authors.lastname: Stein
authors.forename: Marty
authors.initials: M
authors.lastname: Hinz
authors.forename: Thomas
authors.initials: T
authors.lastname: Uncini